PEERSOURCING SOLUTIONS - Key Persons
Adam Persing, PhD is the Chief Data Scientist at PeerSourcing Solutions. Throughout his career, he has applied quantitative solutions to problems across an array of industries. Prior to his time at PeerSourcing Solutions, Adam specialized in data modeling and algorithm design at a Manhattan-based enterprise software startup, aiming to boost the speed of software performance.
Adam also spent time at the World Bank in Washington, DC and McKinsey & Co. in New York. At the World Bank, Adam was a member of a team that identified the major operational hurdles to businesses in developing economies, and at McKinsey & Co., he managed the risk for several portfolios across multiple asset classes within the firm's family office.
Persing was a postdoctoral researcher at University College London in 2013/2014, where he developed fast Monte Carlo methods to help researchers draw more meaningful inferences from genetic sequences. Adam completed a PhD in computational statistics from Imperial College London in 2014, and prior to that, he completed an MS in applied mathematics and statistics and a BS in mathematics and physics, both from Georgetown University, in 2009.
Job Titles:
- Marketing Psychology and Market Research / Professor, Marketing ( Retired ) - Boston College / Professor, Marketing - Curtin University ( Perth )
Brendan Ward is a writer, entrepreneur, strategist, and an award-winning creative director, who has been working in healthcare communications for more than 30 years.
Ward was the Creative Partner and one of the founders of Regan Campbell Ward (RCW), a division of McCann Worldgroup. RCW was a full-service healthcare advertising agency that, during Brendan's tenure, grew to more than 150 employees in two offices. RCW launched ten drugs with more than $1 billion in annual sales. Global campaigns were a core competency at the agency, and Ward led creative development for numerous launches and re-positionings with multiple agency partners around the world.
Previously, Brendan succeeded John Lally and Jim McFarland as the first Chief Creative Officer at Lally McFarland & Pantello, which was recognized by MedAdNews as Most Creative Agency during his tenure.
Ward began his advertising career as a copywriter at Rolf Werner Rosenthal, where he was the senior creative on their launch of RWR's non-prescription advertising division.
Prior to advertising, Brendan was Managing Editor at In Vivo: The Business & Medicine Report and served as Public Affairs Officer at The Jewish Home & Hospital for Aged, the geriatrics teaching partner of Mt. Sinai Medical School.
A serial entrepreneur, Maureen Regan recently founded her second company, PeerSourcing Solutions, with her partners from Regan Campbell Ward (RCW).
In 1997 Regan along with Rich Campbell and Brendan Ward founded Regan Campbell Ward (RCW). With Regan at the helm, RCW became one of the fastest growing and most profitable agencies in the history of healthcare advertising. During her 16-year tenure, RCW launched famous healthcare brands, including ten that surpassed $1 billion in annual sales. She also helped guide the overall healthcare practice at McCann Worldgroup (RCW's parent company) as a member of the Global Leadership Team.
At RCW, Regan built a roster of blue-chip clients, including Allergan, Alexion, Amgen, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Genentech, Gilead, Johnson & Johnson, Kowa Pharmaceuticals, Merck, Millennium, and Novartis. She took RCW from a start-up to $267 million in billings by 2013. The agency won more than 50 advertising awards and in 2006 was named Agency of the Year (Division II) by Med Ad News. Throughout her career, Maureen has been a pioneer and mentor. The first woman to run a major healthcare agency, Regan was named president at Lally, McFarland & Pantello (LM&P) in 1994. In the same year, she was the first agency leader voted HBA "Woman of the Year," an honor received by only 25 women in its history. Regan also received the first McCann Healthcare Leadership award, was named to the PharmaVoice 100 in 2007, and was recognized with the Highest Leaf Award given by the Women's Venture Fund in 2013. In 2016, Regan was named to the inaugural Hall of Femme, a group of women with a record of leadership in healthcare marketing, designated by Medical Marketing & Media.
In more than thirty years in healthcare marketing, Richard Campbell has worn a variety of hats. He started in market research at Pfizer in the early 1980s. After a brief training period in field sales, he moved into brand management where he worked on both ends of the market - serving as an assistant on the launch of a hospital injectable antibiotic, and as manager of a major antidepressant as it lost exclusivity and began facing generic competition. Richard moved from Pfizer to a senior account services role at Lally, McFarland & Pantello (LM&P, now one of the EURO RSCG agencies). At LM&P he worked on Procter & Gamble and American Home Products (now a part of Pfizer) accounts - before moving into a director of marketing role, where he managed the agency's new-business efforts.
In 1997, Campbell and two partners left LM&P to found a new agency with McCann. He served as the strategic partner for Regan Campbell Ward, as the agency grew to almost $40 million in annual revenues, with east and west coast offices and a staff of almost 200. The agency developed expertise in a broad range of categories, including oncology, diabetes, ophthalmology, cardiology and rare diseases. RCW worked with Genzyme on their lysosomal storage disorder portfolio, with Enzon and Sigma Tau on their rare disease offerings, with Novartis as they managed orphan indications for Sandostatin and Ilaris, and with Alexion on Soliris.
Outside of his professional roles, Richard was co-founder of the Moebius Syndrome Foundation, a non-profit seeking to support individuals with Moebius Syndrome and their caregivers, and to help fund research into the rare neuromuscular condition. He is also active with South East Consortium, which provides sports and recreation programs for children and adults with special needs.